Penn Medicine Abramson Cancer Center

 

Penn Medicine Abramson Cancer Center
G

IO for Pancreatic Cancer: Microenvironment and Resistance Mechanisms, Importance of Sequencing Therapies for IO, and Targeting Metastases

By Penn Medicine Abramson Cancer Center FEATURING Gregory Beatty
By Penn Medicine Abramson Cancer Center FEATURING Gregory Beatty
660 views
November 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood
Immunotherapy
16:30

New Immunotherapy Discoveries for NSCLC: What Are Available Approach…

Penn Medicine Abramson Cancer Center

C. Aggarwal

2.2K views
18:16

The Promise of Proton and Stereotactic Radiation Therapy for Early a…

Penn Medicine Abramson Cancer Center

S. Feigenberg

37 views
22:23

IO for Pancreatic Cancer: Microenvironment and Resistance Mechanisms…

Penn Medicine Abramson Cancer Center

G. Beatty

660 views
09:58

How do you make T-cells better?

Penn Medicine Abramson Cancer Center

C. June

525 views
08:13

Challenges and Opportunities with CAR T-cells

Penn Medicine Abramson Cancer Center

C. June

416 views
05:15

Combinatorial Cancer Immunotherapies

Penn Medicine Abramson Cancer Center

C. June

819 views
10:07

Using CAR T in Solid Tumors?

Penn Medicine Abramson Cancer Center

C. June

165 views
08:18

The Making of the Tisagenlecleucel CAR T

Penn Medicine Abramson Cancer Center

C. June

219 views
31:49

CD 19 CAR T-cells in Leukemia

Penn Medicine Abramson Cancer Center

S. Grupp

167 views